Sales 2024 by Business Segment

Sales 2024 by Geography

Historical Breakdown of Revenue by Business Segments

Gross Profit: Breakdown by Business Segment

Breakdown by Business Segment (CNY)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Pharmaceutical Products

          

Pharmaceutical Manufacturing

99Cr 187.72Cr 184.79Cr 211.19Cr 233.25Cr

Gross Profit

70Cr 76Cr 78Cr 98Cr 107.61Cr

Drug Stores and Pharmacies

          

Operation of Chain Pharmacies

- - 70Cr 63Cr 59Cr

Gross Profit

- - 29Cr 24Cr 21Cr

Operation of Chain Pharmacies (Excl. Operation of On-Line Pharmacies)

62Cr 62Cr - - -

Gross Profit

25Cr 26Cr - - -

Elimination of Intersegment Sales

-6.95Cr -82Cr -72Cr -70Cr -71Cr

Online Drug Retail and Pharmacies

          

Operation of On-Line Pharmacies

6.29Cr 7.03Cr - - -

Gross Profit

3.91Cr 4.08Cr - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (CNY)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Mainland China

160.39Cr 174.65Cr 182.59Cr 204.98Cr 221.48Cr

Total Assets

142.05Cr 152.41Cr 187.53Cr 179.26Cr 198.71Cr

Interest Expense

-52.18L -70.8L -65.55L -78.68L -69.94L

Income Tax Expense

2.86Cr 94.47L 2.37Cr 4.34Cr 5.08Cr

D&A

9.75Cr 8.51Cr 9.36Cr 9.95Cr 11Cr

CAPEX

-12Cr -19Cr -8.84Cr -17Cr -14Cr

Gross Profit

99Cr 106.14Cr 107.23Cr 121.81Cr 128.84Cr

Net Income

14Cr 5.21Cr 11Cr 16Cr 9.52Cr

EBT

17Cr 6.18Cr 13Cr 21Cr 15Cr